Schedule 13G ownership disclosure

Elicio Therapeutics, Inc.

Security class unavailable · CUSIP: 28657F103

Event date: 2023-07-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-183388
Form type
SC 13G/A
Filer
Elicio Therapeutics, Inc.
CIK
CIK 1601485
Filed
Jul 07, 2023
Reporting period
Jul 06, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub